Published online before print February 24, 2003, doi: 10.1161/01.CIR.0000056766.45109.C1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:1539.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
Insulin-Stimulated Cyclic Guanosine Monophosphate Inhibits Vascular Smooth Muscle Cell Migration by Inhibiting Ca/Calmodulin-Dependent Protein Kinase II
From the Division of Renal Diseases and Hypertension, Department of Medicine, the University of Texas Health Science Center, Houston (A.M.K., Y.Y., B.C.K., S.Z.), and Department of Medicine, Baylor College of Medicine (J.C.A.), Houston, Tex.
Correspondence to Andrew M. Kahn, MD, University of Texas Medical School, 6431 Fannin, MSB 4.107, Houston, TX 77030. E-mail Andrew.M.Kahn{at}uth.tmc.edu
Background— Insulin resistance is associated with vascular disease. Physiological concentrations of insulin inhibit cultured vascular smooth muscle cell (VSMC) migration in the presence of nitric oxide, and the failure to do so in insulin-resistant states may aggravate vascular disease. We sought to determine the molecular mechanisms by which insulin inhibits VSMC migration.
Methods and Results— Insulin at 1 nmol/L stimulated cGMP production in cultured rat VSMCs that were induced to express inducible nitric oxide synthase (iNOS). VSMC migration was measured in a wound-closure assay, and the platelet-derived growth factor-AB (PDGF-AB)-stimulated component of VSMC migration after wounding was inhibited by insulin, 8-Br-cGMP, and 1-[N-0-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62), a selective inhibitor of calcium/calmodulin-dependent protein kinase II (CaM kinase II). Wounding alone or incubating cells with only PDGF-AB stimulated CaM kinase II activity in an insulin- and 8-Br-cGMP-inhibitable manner. Transfecting VSMCs with a constitutively active CaM kinase II mutant blocked the inhibition by insulin of both wound-induced and wound plus PDGF-AB-induced VSMC migration. High intracellular Ca2+ ([Ca]i)-stimulated CaM kinase II activity was inhibited by 8-Br-cGMP by an okadaic acid-sensitive mechanism.
Conclusions— We conclude that in cultured rat VSMCs expressing iNOS, insulin, via stimulation of cGMP production, inhibits both wound alone-induced and the PDGF-AB-stimulated component of VSMC migration by inhibiting CaM kinase II activity. cGMP inhibits CaM kinase II at a post-[Ca]i step by a protein phosphatase-dependent mechanism.
Key Words: insulin • muscle, smooth • migration • calcium • kinases
This article has been cited by other articles:
 |
|
 |
|
  D. M. Breen, K. K. Chan, J. K. Dhaliwall, M. R. Ward, N. Al Koudsi, L. Lam, M. De Souza, H. Ghanim, P. Dandona, D. J. Stewart, et al. Insulin Increases Reendothelialization and Inhibits Cell Migration and Neointimal Growth After Arterial Injury Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D. N. Dhanasekaran, L. N. Stemmle, et al. Endothelial Nitric Oxide Synthase Inhibits G12/13 and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor: Implication in Vascular Migration Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Mercure, R. Ginnan, and H. A. Singer CaM kinase II{delta}2-dependent regulation of vascular smooth muscle cell polarization and migration Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1465 - C1475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Jones, D. Jourd'heuil, J. C. Salerno, S. M. E. Smith, and H. A. Singer iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2634 - H2642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Piggott, K. A. Hassell, Z. Berkova, A. P. Morris, M. Silberbach, and T. C. Rich Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments J. Gen. Physiol., June 26, 2006; 128(1): 3 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Monti, E. Setola, G. Fragasso, R. P. Camisasca, P. Lucotti, E. Galluccio, A. Origgi, A. Margonato, and P. Piatti Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E54 - E59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Netherton and D. H. Maurice Vascular Endothelial Cell Cyclic Nucleotide Phosphodiesterases and Regulated Cell Migration: Implications in Angiogenesis Mol. Pharmacol., January 1, 2005; 67(1): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Z. Kong, X.-R. Huang, X. Ouyang, J.-J. Tan, G. Fingerle-Rowson, M. Bacher, W. Mu, L. A. Scher, L. Leng, R. Bucala, et al. Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques Cardiovasc Res, January 1, 2005; 65(1): 272 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Harvey, S. S. Banga, and H. L. Ozer Regulation of the Multifunctional Ca2+/Calmodulin-dependent Protein Kinase II by the PP2C Phosphatase PPM1F in Fibroblasts J. Biol. Chem., June 4, 2004; 279(23): 24889 - 24898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pfleiderer, K. K. Lu, M. T. Crow, R. S. Keller, and H. A. Singer Modulation of vascular smooth muscle cell migration by calcium/ calmodulin-dependent protein kinase II-{delta}2 Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1238 - C1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hum, S. Besnard, R. Sanchez, D. Devost, F. Gossard, P. Hamet, and J. Tremblay Characterization of a cGMP-Response Element in the Guanylyl Cyclase/Natriuretic Peptide Receptor A Gene Promoter Hypertension, June 1, 2004; 43(6): 1270 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yang, Y. Yang, S. Zhang, and A. M. Kahn Insulin-Stimulated Hydrogen Peroxide Increases Guanylate Cyclase Activity in Vascular Smooth Muscle Hypertension, October 1, 2003; 42(4): 569 - 573. [Abstract] [Full Text] [PDF]
|
|